首页 | 本学科首页   官方微博 | 高级检索  
     

低分子肝素预防脑出血后深静脉血栓有效性和安全性研究
引用本文:倪杰,钱健,王路娜,王芳,沙杜鹃. 低分子肝素预防脑出血后深静脉血栓有效性和安全性研究[J]. 中国卒中杂志, 2018, 13(6): 562-566. DOI: 10.3969/j.issn.1673-5765.2018.06.006
作者姓名:倪杰  钱健  王路娜  王芳  沙杜鹃
作者单位:210008 南京大学医学院附属南京鼓楼医院急诊医学科
基金项目:南京市医学科技发展项目(YKK15070)
摘    要:
目的 评估自发性脑出血(spontaneous intracerebral hemorrhage,sICH)患者早期皮下注射低分子肝素(low molecular weight heparin,LMWH)预防深静脉血栓形成(deep vein thrombosis,DVT)的有效性。方法 共104例急性sICH患者纳入研究,其中LMWH组51例,对照组53例。LMWH组在入院后第4天开始,连续7 d皮下注射低分子肝素0.4 ml/d;对照组相对应给予下肢间断充气加压(intermittent pneumaticcompression,IPC)措施。两组患者均于入院当天及LMWH治疗第7天检测溶血磷脂酸(lysophosphatidicacid,LPA)水平及抗凝血因子Ⅹa活性,并观察患者有无出血征象。结果 治疗期间所有患者均未出现颅内血肿扩大及再出血事件,与对照组比较,治疗后LMWH组LPA水平(11.74±5.30)ng/ml明显低于对照组(26.81±5.12)ng/ml,比较差异具有统计学意义(P<0.05)。治疗后LMWH组抗凝血因子Xa活性(25.96±7.97)ng/ml明显较对照组(8.06±1.32)ng/ml增高,比较差异具有统计学意义(P<0.05)。结论 急性sICH住院患者为DVT的高发人群,sICH患者在急性期皮下注射低剂量LMWH预防DVT是有效和安全的。

关 键 词:自发性脑出血  深静脉血栓形成  低分子肝素  溶血磷脂酸  抗凝血因子Ⅹa  
收稿时间:2017-10-24

Efficacy and Safety Study on Low Molecular Heparin in the Prevention for Venous Thromboembolism Prophylaxis after Spontaneous Intracerebral Hemorrhage
NI Jie,QIAN Jian,WANG Lu-Na,WANG Fang,SHA Du-Juan. Efficacy and Safety Study on Low Molecular Heparin in the Prevention for Venous Thromboembolism Prophylaxis after Spontaneous Intracerebral Hemorrhage[J]. Chinese Journal of Stroke, 2018, 13(6): 562-566. DOI: 10.3969/j.issn.1673-5765.2018.06.006
Authors:NI Jie  QIAN Jian  WANG Lu-Na  WANG Fang  SHA Du-Juan
Abstract:
Objective To assess the efficacy of low molecular weight heparin (LMWH) for deep vein
thrombosis (DVT) in patients with spontaneous intracerebral hemorrhage (sICH) during early stage.
Methods One hundred and four patients with sICH were enrolled in our study: LMWH group
(n =51) and control group (n =53). The patients of LMWH group were injected hypodermically with
LMWH (Enoxaparin Sodium Injection, 0.4 ml/d) from day 4th to day 10th after admittance. While
the patients in control group received intermittent pneumatic compression (IPC). The LPA and the
anticoagulant factor Xa level were detected on admission day and the treatment of low molecular
heparin for the 7th day in all patients, and whether the patient had bleeding signs were observed.
Results No hematoma enlargement were observed in both groups. After treatment, the serum level
of LPA were significantly lower in LMWH group than that of the control group (11.74±5.30 ng/ml vs
26.81±5.12 ng/ml, P <0.05). The level of anti-Xa were significantly higher in LMWH group than that
of the control group (25.96±7.97 ng/ml vs 8.06±1.32 ng/ml, P <0.05).
Conclusion The hospitalized patients with acute sICH were the crowd with high risk of DVT.
LMWH in doses of 0.4 ml once daily during acute phase in patients with sICH is safe and efficient.
Keywords:Spontaneous intracerebral hemorrhage  Deep vein thrombosis  Low molecular weight heparin  Lysophosphatidic acid  Anticoagulant factor Xa  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国卒中杂志》浏览原始摘要信息
点击此处可从《中国卒中杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号